-
Thermo Fisher Scientific CE Marks Oncomine Dx Target Test
Oct 17, 2018, 11:52 AM by Michael CroftCARLSBAD, CA, UNITED STATES - Oct 17, 2018 - Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumorsFull story -
Evonetix named Best Synthetic Biology Company at OBN Awards
Oct 17, 2018, 09:57 AM by Michael CroftCAMBRIDGE, UK - Oct 12, 2018 - CAMBRIDGE, UK, 12 October 2018 – EVONETIX LTD (Evonetix), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has received the award for Best Emerging Synthetic Biology Company at the 10th Anniversary of the Oxford Bioscience Network (OBN) Awards, in recognition of the Companys novel gene synthesis technology, and its potential to facilitate the rapidly growing field of synthetic biologyFull story -
Opportunity Identification - Zeroing In On The Most Promising Targets
Oct 17, 2018, 08:00 AM by Michael CroftFull storyBio-IT World Contributed Commentary | When tackling opportunity identification, life science and biotech companies need to look at services and technology platforms that can leverage data collection to come up with a targeted list of opportunities and bring on a senior team to develop relationships with them before and after the automated data crunching.
-
Synpromics Unveils Next Generation Liver Selective and Tunable Promoter Platform
Oct 17, 2018, 06:39 AM by Michael CroftEDINBURGH, UK - Oct 17, 2018 - Synpromics is today unveiling its novel drug-regulatable promoter platform at the European Society of Cell and Gene Therapy (ESGCT) congress in Lausanne, SwitzerlandFull story -
Tjoapack and Veratrak launch EPOCH initiative
Oct 16, 2018, 15:22 PM by Michael CroftETTEN LEUR, NETHERLANDS - Sep 9, 2018 - Global contract packaging and supply chain organisation (CPO), Tjoapack and UK-based technology company, Veratrak, have launched the European Platform on Changing Healthcare (EPOCH) as part of their ongoing partnership dedicated to improving pharmaceutical supply chain operationsFull story -
Rho Experts Provide Gene Therapy Development Tips
Oct 16, 2018, 12:59 PM by Michael CroftCHAPEL HILL, NC, UNITED STATES - Oct 16, 2018 - WHAT: Rho, a full-service contract research organization (CRO), will highlight tips for developing gene therapy products in a new free webinar, "Development Advice for Gene Therapy ProductsFull story -
The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
Oct 16, 2018, 12:04 PM by Michael CroftBOSTON, MA - Oct 17, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the winners of its 2018 Presidents Startup Challenge, at its annual member conference in BostonFull story -
The Results Of Your Genetic Test Are Reassuring. But That Can Change.
Oct 16, 2018, 10:00 AM by Michael CroftThe New York Times | Laboratories frequently "reclassify" genetic mutations. But there is no reliable system for telling patients or doctors that the results of their genetic tests are no longer valid.Full story -
Deep Learning-based Genedata Imagence® for Automated High-Content Image Analysis Debuts at SLAS Conference
Oct 16, 2018, 09:24 AM by Michael CroftBASEL, SWITZERLAND - Oct 16, 2018 - Genedata, a leading provider of advanced software solutions for biopharmaceutical R&D, today announced Genedata Imagence®, the industrys first commercial and instrument-agnostic software that automates the analysis of high-content screening (HCS) imagesFull story -
GENEWIZ Introduces CLIA-compliant Next Generation Sequencing Services at ASHG
Oct 16, 2018, 09:17 AM by Michael CroftSOUTH PLAINFIELD, NJ, UNITED STATES - Oct 16, 2018 - Leading global genomics service provider, GENEWIZ, announced at the American Society of Human Genetics (ASHG) Conference (Booth #1237) today that it has expanded its CLIA-compliant service offering into next generation sequencing (NGS)Full story -
Golden Helix Looks Ahead After Receiving NIH Grant For Structural Variation Detection
Oct 16, 2018, 08:15 AM by Michael CroftFull storyBio-IT World | After announcing another grant from the National Institutes of Health to dig further into detecting structural variations, Golden Helix’s CEO and president discusses the company’s history, the shift in trajectory over the past five years, and what’s next.
-
BioIVT Introduces New Quality Management System to Maintain Highest Quality Biospecimens and Drug Development Research Services
Oct 16, 2018, 08:08 AM by Michael CroftWESTBURY, NY, US - Oct 16, 2018 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is introducing a new internal cloud-based Quality Management System (QMS), Master ControlFull story -
Certara’s Synchrogenix Division Collaborates with Hedera Hashgraph to Offer Data Flow and Transparent Collaboration Solutions for the Life Sciences Industry
Oct 15, 2018, 13:34 PM by Michael CroftPRINCETON, NJ, US - Oct 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it has formed a strategic collaboration with Hedera HashgraphFull story -
Ashfield Healthcare Communications appoints new Global Commercial Director
Oct 15, 2018, 11:32 AM by Michael CroftNEWCASTLE UPON TYNE, UNITED KINGDOM - Oct 15, 2018 - Ashfield, part of UDG Healthcare, a leading global healthcare services provider, has appointed Ben Beckley as Global Commercial Director of Ashfield Healthcare CommunicationsFull story -
HiFiBiO Therapeutics Acquires H-Immune Therapeutics
Oct 15, 2018, 08:55 AM by Michael CroftCAMBRIDGE, MASS., PARIS AND SHANGHAI, UNITED STATES - Oct 15, 2018 - HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the acquisition of H-Immune Therapeutics, an early-stage biotechnology company engaged in the discovery and development of novel immuno-oncology therapeuticsFull story -
Takeda On Foundational, Business-Driven, Enabling Data Science
Oct 15, 2018, 08:45 AM by Michael CroftFull storyBio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Krista McKee about the optimal environment to grow data science, the definition of data curation, and more.
-
Advanced Disulfide Bond Analysis Developed by Creative Proteomics
Oct 14, 2018, 22:50 PM by Michael CroftNEW YORK, NY - Oct 15, 2018 - New York – October 15, 2018- Creative Proteomics announced the launching of advanced disulfide bond analysis serviceFull story -
Oxford Nanopore Launches MinIT, Enabling Real Time, Portable DNA Sequencing
Oct 12, 2018, 13:45 PM by Michael CroftFull storyBio-IT World News Brief | Oxford Nanopore has announced they are shipping their new MinIT, a rapid analysis and device control accessory for nanopore DNA sequencing, to genomics researchers.
-
Evonetix wins Best Emerging Synthetic Biology Company at the OBN Awards
Oct 12, 2018, 07:52 AM by Michael CroftLONDON, UK - Oct 12, 2018 - SynbiCITE would like to congratulate Evonetix on winning Best Emerging Synthetic Biology Company at the 10th Annual OBN Awards Ceremony last nightFull story -
MtoZ Biolabs Released a Series of Glycoprotein Analysis Services
Oct 12, 2018, 05:49 AM by Michael CroftBOSTON, MA, US - Oct 12, 2018 - MtoZ Biolabs, a biotechnology company based on mass spectrometry platforms and liquid chromatography technology, announced a series of glycoprotein analysis services, which include glycosylation site analysis and corresponding glycoprotein type analysis at the siteFull story